Time to diagnosis of clinically established Parkinson’s disease or atypical parkinsonism: is a 5-year follow-up period necessary?
Objective: To determine the time frame to the diagnosis of clinically established Parkinson’s disease (PD) or atypical parkinsonism after an acute levodopa challenge (LDC) for…Plasma and fecal short chain fatty acids as predictors for the risk and severity of Parkinson’s Disease
Objective: To delineate the influence of plasma and fecal short chain fatty acids (SCFAs) on the risk and severity of Parkinson’s disease (PD). Background: Recent…Back pain in Parkinson’s disease: an underestimated problem
Objective: Estimate the importance of back pain (BP) in Parkinson's disease (PD) and its impact on quality of life. Background: Parkinson's disease (PD) is a…Dance training and performance in patients with Parkinson disease: effects on motor functions and patients’ well-being.
Objective: Evaluate the effects of a 16-week a specific dance training program on motor function and well-being in patients with Parkinson Disease (PD). Background: Dance…Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area
Objective: To assess morbidity and mortality of acute COVID-19 infection in hospitalized patients with neurodegenerative diseases and compare with age-matched controls. Background: Outcomes from COVID-19…Effect of physical exercises on gait speed in patients with Parkinson’s disease
Objective: To verify the effect of the application of physical exercises with a dual task on gait speed and the occurrence of falls in people…Early versus later levodopa and onset of motor fluctuations in PD: Observations from the Parkinson’s Outcomes Project
Objective: To characterize patients with early versus later levodopa exposure, defining “early” as within 2 years of Parkinson’s disease (PD) diagnosis, and to determine whether…Predictors of survival in Progressive Supranuclear Palsy in a Tunisian cohort
Objective: To investigate survival and its determinants in a Tunisian cohort of Progressive Supranuclear Palsy (PSP). Background: PSP is a neurodegenerative tauopathy characterized by faster…How Covid-19 would affect parkinsonism patients’ mortality
Objective: To investigate the prevalence and mortality of Covid-19 among parkinsonism patients in addition to worsening of motor symptoms of these patients. Background: Parkinsonism can…Determination of 5-HT3 receptor levels with [3H]-GR 65630 binding in hemi-parkinsonian rats with L-DOPA induced dyskinesia
Objective: To determine the distribution of serotonin type 3 (5-HT3) receptors in brain areas implicated in L-3,4-dihydroxyphenylalanine (L-DOPA) induced dyskinesia in the 6-hydroxydopamine (6-OHDA)-lesioned rat…
- « Previous Page
- 1
- …
- 67
- 68
- 69
- 70
- 71
- …
- 405
- Next Page »